Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity

Anticancer Research

Volumn 30, Issue 10, 2010, Pages 3919-3925

  Ramachandran, Kavitha ^a   Miller, Heather ^a   Gordian, Edna ^a   Rocha Lima, Caio ^a   Singal, Rakesh ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Chemotherapy; DNA methylation; Epigenetics; Pancreatic cancer

Indexed keywords

AZACITIDINE; DOCETAXEL; GEMCITABINE; PROTEIN; TARGET OF METHYLATION INDUCED SILENCING 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL VIABILITY; CHEMOSENSITIVITY; DNA METHYLATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AZACITIDINE; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; DEOXYCYTIDINE; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; GENE SILENCING; HUMANS; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; TAXOIDS; TRANSFECTION;

EID: 78650255142     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer Statistics, 2010. CA Cancer J Clin 2010.
2. Carmichael J, Fink U, Russell RC, Spittle MF, Harris AL, Spiessi G and Blatter J: Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer 73: 101-105, 1996. (Pubitemid 26026268)
3. Jiang PH, Motoo Y, Sawabu N and Minamoto T: Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells. World J Gastroenterol 12: 1597-1602, 2006.
4. Meggiato T, Calabrese F, De Cesare CM, Baliello E, Valente M and Del Favero G: C-JUN and CPP32 (CASPASE 3) in human pancreatic cancer: relation to cell proliferation and death. Pancreas 26: 65-70, 2003. (Pubitemid 36020268)
5. Androulakis N, Kourousis C, Dimopoulos MA, Samelis G, Kakolyris S, Tsavaris N, Genatas K, Aravantinos G, Papadimitriou C, Karabekios S, Stathopoulos GP and Georgoulias V: Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study. J Clin Oncol 17: 1779-1785, 1999.
6. Rougier P, Adenis A, Ducreux M, de Forni M, Bonneterre J, Dembak M, Clouet P, Lebecq A, Baille P, Lefresne-Soulas F, Blanc C and Armand JP: A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma. Eur J Cancer 36: 1016-1025, 2000.
7. Wang LG, Liu XM, Kreis W and Budman DR: The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 44: 355-361, 1999.
8. Fabbri F, Carloni S, Brigliadori G, Zoli W, Lapalombella R and Marini M: Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: a cytometric study. BMC Cell Biol 7: 6, 2006.
9. Haldar S, Chintapalli J and Croce CM: Taxol induces BCL-2 phosphorylation and death of prostate cancer cells. Cancer Res 56: 1253-1255, 1996.
10. McConnell BB and Vertino PM: TMS1/ASC: the cancer connection. Apoptosis 9: 5-18, 2004.
11. McConnell BB and Vertino PM: Activation of a caspase-9-mediated apoptotic pathway by subcellular redistribution of the novel caspase recruitment domain protein TMS 1. Cancer Res 60: 6243-6247, 2000.
12. Levine JJ, Stimson-Crider KM and Vertino PM: Effects of methylation on expression of TMSlIASC in human breast cancer cells. Oncogene 22: 3475-3488, 2003.
13. Virmani A, Rathi A, Sugio K, Sathyanarayana UG, Toyooka S, Kischel FC, Tonk V, Padar A, Takahashi T, Roth JA, Euhus DM, Minna JD and Gazdar AF: Aberrant methylation of TMS1 in small cell, non-small cell lung cancer and breast cancer. Int J Cancer 106: 198-204, 2003. (Pubitemid 36835171)
14. Terasawa K, Sagae S, Toyota M, Tsukada K, Ogi K, Satoh A, Mita H, Imai K, Tokino T and Kudo R: Epigenetic inactivation of TMS1/IASC in ovarian cancer. Clin Cancer Res 10: 2000-2006, 2004.
15. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL and Paul CL: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89: 1827-1831, 1992.
16. Singal R, Ferris R, Little JA, Wang SZ and Ginder GD: Methylation of the minimal promoter of an embryonic globin gene silences transcription in primary erythroid cells. Proc Natl Acad Sci USA 94: 13724-13729, 1997.
17. Gordian E, Ramachandran K and Singal R: Methylation mediated silencing of TMS1 in breast cancer and its potential contribution to docetaxel cytotoxicity. Anticancer Res 29: 3207-3210, 2009.
18. Ramachandran K, Gopisetty G, Gordian E, Navarro L, Hader C, Reis IM, Schulz WA and Singal R: Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target. Cancer Res 69: 1527-1535, 2009.
19. Das PM and Singal R: DNA methylation and cancer. J Clin Oncol 22: 4632-4642, 2004.
20. Omura N and Goggins M: Epigenetics and epigenetic alterations in pancreatic cancer. Int J Clin Exp Pathol 2: 310-326, 2009.
21. Sato N and Goggins M: The role of epigenetic alterations in pancreatic cancer. J Hepatobiliary Pancreat Surg 13: 286-295, 2006.
22. Das PM, Ramachandran K, Vanwert J, Ferdinand L, Gopisetty G, Reis IM and Singal R: Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Mol Cancer 5: 28, 2006.
23. Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST and Vertino PM: TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res 60: 6236-6242, 2000.
24. Akahira J, Sugihashi Y, Ito K, Niikura H, Okamura K and Yaegashi N: Promoter methylation status and expression of TMS1 gene in human epithelial ovarian cancer. Cancer Sci 95: 40-43, 2004.
25. Hasegawa M, Kawase K, Inohara N, Imamura R, Yeh WC, Kinoshita T and Suda T: Mechanism of ASC-mediated apoptosis: bid-dependent apoptosis in type II cells. Oncogene 26: 1748-1756, 2007.
26. Masumoto J, Dowds TA, Schaner P, Chen FF, Ogura Y, Li M, Zhu L, Katsuyama T, Sagara J, Taniguchi S, Gumucio DL, Nunez G and Inohara N: ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochem Biophys Res Commun 303: 69-73, 2003.
27. Parsons MJ and Vertino PM: Dual role of TMS1/ASC in death receptor signaling. Oncogene 25: 6948-6958, 2006.
28. Parsons MJ, Patel P, Brat DJ, Colbert L and Vertino PM: Silencing of TMS1/ASC promotes resistance to anoikis in breast epithelial cells. Cancer Res 69: 1706-1711, 2009.
29. Egger G, Liang G, Aparicio A and Jones PA: Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463, 2004.
30. Karpf AR and Jones DA: Reactivating the expression of methylation-silenced genes in human cancer. Oncogene 21: 5496-5503, 2002.